First Trust Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

First Trust Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-177,541	Closed	-$4.24M	–	2598
2021 Q1	$4.24M	Sell	177,541 -1,959	-1%	-$36.4K	0.01%	1339
2020 Q4	$2.62M	Buy	+179,500	New	+$2.38M	﹤0.01%	1442

First Trust Advisors's GNMK Position: Q2 2021 in Review

First Trust Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 177,541 shares — an estimated $4.24M sold.

First Trust Advisors first reported a position in GNMK in Q4 2020 and held it in 2 quarters. The position peaked at $4.24M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

First Trust Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
First Trust Advisors sold 177,541 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4.24M.
First Trust Advisors first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 2 quarters.
First Trust Advisors's GenMark Diagnostics, Inc position peaked at $4.24M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on First Trust Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.